Live Breaking News & Updates on Director Richard Barry|Page 1

Stay updated with breaking news from Director richard barry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Sigma Planning Corp Purchases 300 Shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Sigma Planning Corp lifted its holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 2.5% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 12,405 shares of the biotechnology company’s stock after purchasing an additional 300 shares during the period. Sigma Planning Corp’s holdings in Sarepta Therapeutics […] ....

New Zealand General , New Zealand , Douglass Ingram , Richard Barry , Sigma Planning Corp , Cantor Fitzgerald , York Mellon Corp , Royal Bank , Sarepta Therapeutics Inc , Blackrock Inc , Geode Capital Management , Securities Exchange Commission , Wellington Management Group , Sarepta Therapeutics , Free Report , Planning Corp , Management Group , New York Mellon Corp , Street Corp , Capital Management , Exchange Commission , Director Richard Barry , Get Free Report , Sarepta Therapeutics Daily , Nasdaq Srpt , Sec Filings ,

Sarepta Therapeutics (NASDAQ:SRPT) Given "Buy" Rating at Needham & Company LLC

Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report)‘s stock had its “buy” rating reissued by Needham & Company LLC in a report issued on Monday, Benzinga reports. They presently have a $140.00 price objective on the biotechnology company’s stock. Needham & Company LLC’s price target suggests a potential upside of 15.05% from the company’s previous close. […] ....

Douglass Ingram , Richard Barry , Partners Investment Advisory , Securities Exchange Commission , Needham Company , Qube Research Technologies Ltd , Cantor Fitzgerald , First Horizon Advisors Inc , Jpmorgan Chase Co , Sarepta Therapeutics Inc , Montaga Associates Inc , Sarepta Therapeutics , Get Free Report , Director Richard Barry , Exchange Commission , Wealth Management , Horizon Advisors , Street Partners Investment Advisory , Qube Research , Technologies Ltd , Sarepta Therapeutics Daily , Nasdaq Srpt , Reiterated Rating , Needham Company Llc ,